HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma

The present data underscore the critical pathogenetic, prognostic, and therapeutic role of HSF1 in cholangiocarcinogenesis.

Authors

Institutions

Publication Details

Journal
Journal of Experimental & Clinical Cancer Research
Published
2024-09-06
DOI
https://doi.org/10.1186/s13046-024-03177-7
Citations
5
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
2.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma

Serena Mancarella, Sara Steinmann, Elena Antinoro Pizzuto, Isabella Gigante et al.
5 citations
Journal of Experimental & Clinical Cancer Research
Cholangiocarcinoma and Gallbladder Cancer Studies
2.86
article

HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma

Serena Mancarella, Sara Steinmann, Elena Antinoro Pizzuto, Isabella Gigante, Matthias Evert, Xin Chen, Giovanni Mario Pes, Francesco Urigo, Li Che, Antonio Cigliano, Maria Pina Dore, Rosa M. Pascale, Gianpaolo Vidili, Gianluigi Giannelli, Marina Serra, Silvia Ribback, Egle Milia, Diego F. Calvisi, Eleonora Cossu, Maria M. Simile
article en
5 citations

Abstract

The present data underscore the critical pathogenetic, prognostic, and therapeutic role of HSF1 in cholangiocarcinogenesis.

Journal of Experimental & Clinical Cancer ResearchVol. 43(1)
University of Hawaiʻi at Mānoa (US), University of Hawaii System (US), University of Sassari (IT), University of Cagliari (IT), University of California, San Francisco (US), Universität Greifswald (DE), Cancer Center of Hawaii (US), Gastroenterology Hospital "Saverio de Bellis" (IT), University of Hawaii Cancer Center, University of Regensburg (DE)
Fondazione di Sardegna, Associazione Italiana per la Ricerca sul Cancro, Università degli Studi di Sassari, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 9%
Cholangiocarcinoma and Gallbladder Cancer Studies
2.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.